Beer Ingredient May Slow Alzheimer's, Parkinson's Development
the Psychiatry Advisor take:
Evidence has suggested that oxidative damage to neuronal cells contributes to the development of neurodegenerative diseases. If researchers found a way to protect these cells, it could potentially slow or even prevent the onset of neurodegenerative diseases.
Lately, many studies have focused on the health benefits of wine, but scientists are accumulating evidence that beer could have more health properties than previously thought.
In a new study published in the Journal of Agricultural and Food Chemistry, the researchers have found that a compound in hops, called xanthohumol, has anti-oxidation, cardiovascular protection, and anticancer properties.
The researchers tested the effects of xanthohumol on brain cells. Lab tests showed that the compound was successful in protecting neuronal cells from oxidative damage.
Because xanthohumol has shown protective properties for brain cells, it may be a candidate for the prevention or delaying of neurodegenerative diseases. The current findings are preliminary, but the results are promising. Further studies are needed to determine the safety and efficacy of xanthohumol as a preventative measure or treatment for diseases like Alzheimer’s and Parkinson's.
Compound in Beer May Slow Alzheimer's, Parkinson's Development
The health-promoting perks of wine have attracted the spotlight recently, leaving beer in the shadows, researchers said.
But scientists are discovering new ways in which the latter could be a more healthful beverage than once thought.
Researchers report in ACS' Journal of Agricultural and Food Chemistry that a compound from hops could protect brain cells from damage - and potentially slow the development of disorders such as Alzheimer's and Parkinson's diseases.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- FDA Approves Schizophrenia Medication With Digital Ingestion Sensor
- Increased Depression Severity Following Childhood Exposure to Adversity, Risk
- Suboptimal Neuromotor Development Related to Genetic Risk for Schizophrenia
- No Association Between Comorbid Anxiety Disorders, Suicide Attempts
- Cannabidiol Concentration, Labeling Varies Widely in Products Sold Online
- Maintenance rTMS for Treatment-Resistant Depression
- Eye Movement Desensitization and Reprocessing Reduces PTSD Symptoms
- Micronutrients Improve Some Symptoms of ADHD
- Long-Acting Injectable Antipsychotics Delay Schizophrenia Relapse
- Transcranial Stimulation Reduces Auditory Hallucinations in Schizophrenia
- ADHD Medication Exposure Associated With Increased Neonatal Mortality
- Frequent Migraines Increase Severity of Anxiety, Depression
- Abnormal MRI and CSF Findings May Predict Risk for Alzheimer's Dementia
- Genetic Link Between Obesity Traits, Depression With Atypical Features
- Improved Outcomes for Patients Treated by Own PCP During Hospital Stay